SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,129,325 | -3.6% | 29,610 | -1.0% | 0.00% | 0.0% |
| Q3 2022 | $1,171,000 | +56.1% | 29,910 | +28.8% | 0.00% | +100.0% |
| Q2 2022 | $750,000 | -68.9% | 23,215 | -68.1% | 0.00% | -66.7% |
| Q1 2022 | $2,408,000 | -58.1% | 72,735 | -46.1% | 0.00% | -57.1% |
| Q4 2021 | $5,744,000 | +4.0% | 135,035 | +8.3% | 0.01% | -12.5% |
| Q3 2021 | $5,523,000 | -37.2% | 124,635 | -19.5% | 0.01% | -33.3% |
| Q2 2021 | $8,796,000 | +171.5% | 154,835 | +257.7% | 0.01% | +140.0% |
| Q1 2021 | $3,240,000 | -20.9% | 43,290 | -8.6% | 0.01% | -28.6% |
| Q4 2020 | $4,097,000 | +161.8% | 47,348 | +85.0% | 0.01% | +133.3% |
| Q3 2020 | $1,565,000 | +377.1% | 25,590 | +224.3% | 0.00% | +200.0% |
| Q2 2020 | $328,000 | -52.4% | 7,890 | -67.1% | 0.00% | -50.0% |
| Q1 2020 | $689,000 | -72.5% | 23,997 | -31.0% | 0.00% | -50.0% |
| Q4 2019 | $2,508,000 | +585.2% | 34,754 | +1231.1% | 0.00% | +300.0% |
| Q3 2019 | $366,000 | -23.8% | 2,611 | -0.3% | 0.00% | 0.0% |
| Q2 2019 | $480,000 | +21.8% | 2,619 | +5.8% | 0.00% | 0.0% |
| Q1 2019 | $394,000 | +75.9% | 2,476 | +5.9% | 0.00% | – |
| Q4 2018 | $224,000 | -30.7% | 2,339 | +2.1% | 0.00% | – |
| Q3 2018 | $323,000 | -5.8% | 2,290 | +4.6% | 0.00% | -100.0% |
| Q2 2018 | $343,000 | -49.6% | 2,190 | -48.1% | 0.00% | 0.0% |
| Q1 2018 | $680,000 | +7.1% | 4,220 | +9.5% | 0.00% | 0.0% |
| Q4 2017 | $635,000 | +166.8% | 3,854 | +0.9% | 0.00% | – |
| Q3 2017 | $238,000 | -31.4% | 3,818 | -12.4% | 0.00% | -100.0% |
| Q2 2017 | $347,000 | +54.2% | 4,358 | +37.6% | 0.00% | – |
| Q1 2017 | $225,000 | -40.5% | 3,168 | -57.3% | 0.00% | -100.0% |
| Q4 2016 | $378,000 | +12.8% | 7,414 | +1.9% | 0.00% | 0.0% |
| Q3 2016 | $335,000 | – | 7,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |